Waters Corporation (WAT)
Waters Corporation R&D Expense: 23.35M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
WAT R&D Expense Rankings
| Overall | 19th percentile | 1418 of 1762 |
| Sector | 18th percentile | 337 of 415 in Healthcare |
| Industry | 17th percentile | 57 of 69 in Medical Appliances & Equipment |
WAT R&D Expense Range, Past 5 Years
| Minimum | 18.33M | Mar 2009 |
| Maximum | 23.71M | Dec 2011 |
| Average | 21.03M |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these WAT related companies
WAT News
Waters Unveils New Analytical Tools for Research and Routine Screening Applications at ASMS 2012
May 21, 3:34PM PR Newswire
May 21, 3:34PM PR Newswire
sometimes it saves to look back a ways. weekly pattern looking suspicious. $WAT http://chart.ly/96dj9um
about 11 days ago by stubbybrown
about 11 days ago by stubbybrown
Wells Fargo Starts Waters Corp. (WAT) at Outperform; End-market Positioning
May 17, 9:32AM Street Insider
May 17, 9:32AM Street Insider
Waters Corporation Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to Be Webcast Live
May 10, 7:00AM Business Wire
May 10, 7:00AM Business Wire
Waters Corporation Presentation at the Baird 2012 Growth Stock Conference to Be Webcast Live
May 07, 7:00AM Business Wire
May 07, 7:00AM Business Wire
Waters Corporation Presentation at the Deutsche Bank 37th Annual Health Care Conference to Be Webcast Live
May 04, 7:00AM Business Wire
May 04, 7:00AM Business Wire
Auriga Reiterates a 'Buy' on Waters Corp. (WAT); Unexpectedly High Decline at Big Pharma Drags Down Results
Apr 25, 10:21AM Street Insider
Apr 25, 10:21AM Street Insider
$WAT 200 Day SMA Cross - Price crossed above 200 day SMA (82.2248). Confirmed by volume.
about 37 days ago by TradeIdeasQuant
about 37 days ago by TradeIdeasQuant
@gtlackey I have $WAT on my list, but I don't like it continuing to test Supp here. Thoughts?
about 37 days ago by 1nvestor
about 37 days ago by 1nvestor
Listen to $WAT Q1 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3Tf0
about 38 days ago by earningscast
about 38 days ago by earningscast
$SPX components that traded beyond their 14-day ATR (based off open): $HAS $K $UNP $WAT $AKAM $MET $FAST http://stks.co/3T9I
about 39 days ago by Attitrade
about 39 days ago by Attitrade
Waters Brings Awarding-Winning UltraPerformance Convergence Chromatography to Analytica 2012
Apr 17, 3:00AM PR Newswire
Apr 17, 3:00AM PR Newswire
VICAM's New Fumo-V Strip Tests Delivers Accurate Detection of Fumonisin Mycotoxins in Minutes
Mar 30, 12:01PM PR Newswire
Mar 30, 12:01PM PR Newswire
$WAT filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/39X4
about 63 days ago by MarketBrief
about 63 days ago by MarketBrief
RT @SFOmag: The longer the consolidation, the bigger the breakout @upsidetrader says $WAT is in a bullish coil http://stks.co/2o2j
about 80 days ago by howardlindzon
about 80 days ago by howardlindzon
Area. Nice up move, now digesting gains in the box. Potential 100 Roll candidate. $WAT http://chart.ly/kbx85dj
about 104 days ago by 1nvestor
about 104 days ago by 1nvestor
RT @TheEquitiesRoom EBR: Watchlist/worksheet/3 Trading Ideas: $WAT $TJX $UEC http://stks.co/2ShM
about 105 days ago by TheFuturesRoom
about 105 days ago by TheFuturesRoom
EBR: Watchlist/worksheet/3 Trading Ideas: $WAT $TJX $UEC http://stks.co/2SYR
about 105 days ago by TheEquitiesRoom
about 105 days ago by TheEquitiesRoom
$SPY 72 NR7 Day Alerts for the S&P 500 Stocks. $NVLS $M $WAT charts showing possible bull flags to watch. http://stks.co/2ID1
about 115 days ago by tradewithpete
about 115 days ago by tradewithpete
$WAT Insider Sale: $5.2M of stock sold by Arthur Caputo (Evp And President, Waters Div) on January 31, 2012 http://stks.co/2D4H
about 120 days ago by MarketBrief
about 120 days ago by MarketBrief
Waters Corp, $WAT moves above 70 DMA, has Bullish signals on Weekly Candlestick Chart http://chart.ly/n5k28pd
about 124 days ago by InvestProfits
about 124 days ago by InvestProfits
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| WAT | 79.78 | -1.02 | -1.26% | 7.105B |
| VSH | 10.62 | -0.09 | -0.84% | 1.670B |
| VSEC | 24.55 | +0.68 | +2.85% | 128.89M |
| VSCP | 1.01 | -0.03 | -2.88% | 29.66M |
| VSBN | 10.55 | +0.00 | +0.00% | 18.88M |
| VSAT | 42.02 | +0.38 | +0.91% | 1.800B |
| VRX | 48.66 | +0.74 | +1.54% | 14.92B |
| VRTX | 60.04 | -0.14 | -0.23% | 12.63B |
| VRTS | 70.88 | +0.51 | +0.72% | 545.78M |
| VRTB | 1.260 | -0.00 | -0.01% | 16.56M |
